thalidomide for transfusion-dependent beta thalassemia
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial tests different doses of thalidomide to see if it can reduce or eliminate the need for blood transfusions in people with beta thalassemia major or intermedia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with beta thalassemia major or intermedia
- You need regular blood transfusions (at least 8-12 per year)
- You are not pregnant or breastfeeding
- You are not married
- You do not have liver disease, a history of seizures, or blood clots
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving you your own (autologous) gene-modified blood stem cells can improve transfusion-dependent beta-thalassemia and its safety. It may help people who do not have a fully matched donor and need an alternative approach to care.
This trial tests if certain drugs can safely increase fetal hemoglobin (a type of hemoglobin that helps carry oxygen) in people with beta thalassemia major. It may offer a new way to manage the condition and reduce the need for transfusions.
This study tests whether a combination of two drugs, luspatercept and thalidomide, can help people with beta-thalassemia who need regular blood transfusions. It aims to reduce the number of transfusions needed.
This trial tests a gene therapy to help people with transfusion-dependent beta-thalassemia (a severe type of thalassemia) stop needing regular blood transfusions. It uses your own stem cells, which are modified to produce healthy red blood cells.
This early study tests the safety and potential benefit of the LentiRed gene-based drug in people with transfusion-dependent beta-thalassemia (TDT) who are planning an autologous stem cell transplant. It may help reduce the severity of anemia, but the main goal at this stage is to check safety and side effects.
This trial tests a one-time gene therapy using your own blood stem cells to treat severe beta-thalassemia. It may help you stop needing regular blood transfusions.
Hear when a new Fetal Hemoglobin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.